Clinical Trials Logo

Clinical Trial Summary

Rationale: The construction of esophageal anastomoses is associated with considerable risk at postoperative anastomotic leakage. Application of TachoSil®, a tissue sealant with human fibrinogen and thrombin, can improve strength of the esophageal anastomosis and potentially prevent anastomotic leakage.

Objective: Evaluation of feasibility and safety of TachoSil® application on esophageal anastomoses.

Study design: Non-randomized, non-blinded, single-center intervention study. Study population: Patients, 18-80 years old, undergoing an elective total gastrectomy with an esophago-jejunostomy or esophagectomy with a planned esophagogastric anastomosis will be enrolled. A total number of 15 patients will be included in the study.

Intervention: Gastric or esophageal resection will be executed according to the common procedures used in the UMC Utrecht. After construction of the esophageal anastomosis, all enrolled participants will receive a TachoSil® patch, which will be applied on the esophageal anastomosis intra-operatively. Hence, TachoSil® is used as an add-on therapy. TachoSil® will be degraded enzymatically in a period of approximately 24 weeks after application.

Main study parameters/endpoints: The primary endpoint is feasibility, which is assessed by evaluation of adherence of the patch. A time-action analysis of the application of the Tachosil patch will be performed.

Nature and extent of the burden associated with participation: The burden for the patient is minimal. The total surgical procedure will be prolonged with 10-15 minutes. Postoperative care and outpatient visits do not differ from regular protocol. TachoSil® is approved and registered for supportive treatment in surgery for improvement of haemostasis and to promote tissue sealing by the European Commission.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02105506
Study type Interventional
Source UMC Utrecht
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT03198871 - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Phase 4
Not yet recruiting NCT06212206 - PillBotâ„¢ - Remotely Controlled Capsule Endoscopy N/A
Not yet recruiting NCT03092414 - Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions N/A
Completed NCT03776916 - Application of Simethicone in Esophagogastroscopy N/A
Not yet recruiting NCT06273319 - The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications N/A
Not yet recruiting NCT02994472 - Gastric Emptying: in Vivo Studies in Healthy Volunteers N/A
Recruiting NCT03267355 - Indications and Outcomes of Endoscopic Ultrasound in Tanta N/A
Completed NCT01322737 - Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System N/A
Completed NCT04111393 - Transoral Removal of Specimen During Laparoscopic Gastric Resection
Recruiting NCT05249933 - Pronase Granules in Gastric Cleaning Phase 2/Phase 3
Completed NCT04479423 - The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy N/A
Completed NCT05392452 - Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB) N/A
Not yet recruiting NCT05801055 - A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone Phase 3